Want to join the conversation?
Generic & specialty pharmaceuticals company $MYL said that it has agreed to join forces with $MNTA to develop, manufacture and commercialize six of $MNTA's biosimilar candidates, plus ORENCIA (abatacept). As per the agreement, $MYL will make an up-front cash payment of $45MM and up to $200MM in contingent milestone-related payments to $MNTA.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!